Orphazyme to lead the way for more biotech IPOs

Last week, Orphazyme carried out the first IPO of a Danish biotech company in seven years. Now, the company has many expectations to meet, for instance, branding Denmark as an attractive country for biotech companies to go public.

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us free for 14 days

Try a trial subscription for free access to our quality journalism

Frontpage right now

Latest Top picks in English

Related articles